Live Breaking News & Updates on Diagnostic Solutions Segment
Stay updated with breaking news from Diagnostic solutions segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Denny Jacob Ligand Pharmaceuticals shares were 21% higher at $89.98 following better-than-expected results in its fourth quarter. The stock is up about. ....
By Ben Glickman Shares of Verve Therapeutics rose Tuesday after fourth-quarter collaboration revenue came in ahead of expectations. The stock was up 16% to. ....
By Sabela Ojea Shares of SI-BONE on Tuesday dropped a day after the company posted a wider-than-expected loss in the latest quarter. At 12:23 p.m. ET, shares. ....
By Colin Kellaher The Food and Drug Administration has officially pulled its authorization of the anticancer drug Pepaxto from Swedish biotech Oncopeptides.. ....